FiND Terminal

Cadila Healthcare leads ANDA approvals among Indian drug makers

Posted on Updated on

Cadila Healthcare secured the highest number of ANDA (abbreviated new drug application) approvals among Indian pharmaceutical companies during the past nine month period.

The country’s fourth-largest drugmaker by market cap has received 70 ANDA approvals in the current financial year (Image 1). Out the total, 21 ANDA approvals were received by the company during the previous quarter. 

The drug makers are required to obtain ANDA approval from the FDA to manufacture and market the low-cost generic alternative to the brand-name drug in the US market.

Cadila Healthcase - ANDA
[Image 1: FiND Compare screen highlights ANDA approvals for top 5 Indian drugmakers]
Read the rest of this entry »